Compare · BLCO vs LUCY
BLCO vs LUCY
Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLCO and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- Over the past year, BLCO is up 16.0% and LUCY is down 48.8% - BLCO leads by 64.8 points.
- BLCO has been more active in the news (7 items in the past 4 weeks vs 3 for LUCY).
- BLCO has more recent analyst coverage (18 ratings vs 0 for LUCY).
- Company
- Bausch + Lomb Corporation
- Innovative Eyewear Inc.
- Price
- $15.83+0.41%
- $1.06+0.95%
- Market cap
- -
- -
- 1M return
- -1.06%
- -3.64%
- 1Y return
- +15.97%
- -48.79%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2022
- News (4w)
- 7
- 3
- Recent ratings
- 18
- 0
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Latest BLCO
- Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
- Bausch + Lomb Releases 2025 Sustainability Impact Report
- Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
- SEC Form DEF 14A filed by Bausch + Lomb Corporation
- Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
- Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
- Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
- Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
- Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
- SEC Form 4 filed by Bausch + Lomb Corporation
Latest LUCY
- Innovative Eyewear, Inc. Announces Preliminary Q1 2026 Results
- Innovative Eyewear, Inc. Receives Red Dot Design Award on Lucyd Armor Smart Safety Glasses
- Innovative Eyewear, Inc. Announces New Reebok Optical Collection and Retail Placements
- Innovative Eyewear, Inc. Announces New Smart Safety Glasses and Rx Safety Partner
- Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
- SEC Form 10-K filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Q4 and Full Year 2025 Earnings Conference Call
- Innovative Eyewear, Inc. Announces New Distribution with Major European Retailer MODIVO Group
- Innovative Eyewear, Inc. Receives Notice of Patent Allowance for Smartglasses Charging Cradle
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.